Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07630220

The Effect of Standard vs. Shorter Filter Lifespan During Continuous Renal Replacement Therapy

This study aims to investigate shorter vs. standard filter lifespans in critically ill patients receiving continuous renal replacement therapy (CRRT) for acute kidney injury (AKI). The aim of this trial is to reliably implement,scheduled filter changes and to investigate whether shorter filter lifetime is associated with a lower incidence in rate of new infections.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Own data of patients under standard care indicated that a longer filter lifetime in CRRT is associated with an increased rate of new infections.

The aim of this study is to demonstrate that a protocolized filter-change strategy can be reliably implemented in critically ill patients and a high protocol adherence can be achieved.

The secondary aim is to investigate whether a shorter filter-change strategy is be associated with a lower incidence of newly acquired infections.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult ≥ 18 years
  • Critically ill patients with severe AKI consistent with KDIGO stage 3 and an absolute indication for CRRT
  • Written consent form from the patient or legal representative or authorized representative or emergency inclusion

Exclusion criteria

  • End-stage kidney disease or chronic dialysis dependence
  • Chronic kidney disease with eGFR<20ml/min/1.73 m²
  • Prior kidney transplant
  • Prior renal replacement therapy during the index admission before randomization
  • Glomerulonephritis, interstitial nephritis, vasculitis
  • Patients on immunosuppression (above the cushing threshold)
  • Patients with chronic inflammatory diseases (e.g. arthritis, HIV with a CD4 count of < 0.05 x 10E/l)
  • Do-not resuscitate order
  • Persons with any kind of dependency on the investigator or employed by the sponsor
  • Patients participating in an interventional study involving measures to influence the immune system

Treatment and study plan

time span of filter change

Other

The time span of the filter change during continuous renal replacement therapy will be specified

Primary outcomes

  1. Mean filter lifespan per patient

    Time frame: From start of CRRT to end of CRRT or at day 30 after randomization, whatever occurs first

    Comparison of mean filter lifespans between study groups

  2. Protocol adherence as documented filter change within the specified period

    Time frame: From start of CRRT to end of CRRT or at day 30 after randomization, whatever occurs first

    Proportion of protocol adherent patients, defined as patients with mean filter lifespan within the pre-specified time window in each arm (intervention group: 36±3hours; control group: 48-72hours

Secondary outcomes

  1. New intensive care unit (ICU)-associated acquired infection up to day 30

    Time frame: From start of CRRT to end of CRRT or at day 30 after randomization, whatever occurs first

    Rate of new ICU-acquired infections, defined as new infection in patients with pre-existing infection but with another pathogen than baseline or without baseline infection. All infections need to be culture proven. Only the first infection per patient will be considered

Study contacts

Contact information is provided by the study sponsor or research team.

Alexander Zarbock, MD

CONTACT

[email protected]

+49-251-8347255

Nadja Schöne, MD

CONTACT

[email protected]

+49-8347262

Sponsors and collaborators

Lead sponsor

Universität Münster

Other

Registry information

Official study title

The Effect of Standard vs. Shorter Filter Lifespan During Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury - a Feasibility Randomized Controlled Trial

Acronym: SPECIAL

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jun 5, 2026
Registry last updated
Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.